Systems analysis of arrestin pathway functions

Progress in Molecular Biology and Translational Science

Volumn 118, Issue , 2013, Pages 431-467

  Maudsley, Stuart ^a   Siddiqui, Sana ^a   Martin, Bronwen ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879100775     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394440-5.00017-6     Document Type: Chapter

References (158)

1. S. Maudsley, B. Martin, and L.M. Luttrell The origins of diversity and specificity in G protein-coupled receptor signaling J Pharmacol Exp Ther 314 2005 485 494
2. C.B. Brink, B.H. Harvey, J. Bodenstein, D.P. Venter, and D.W. Oliver Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology Br J Clin Pharmacol 57 2004 373 387
3. B.V. Cheney, R.A. Lahti, C. Barsuhn, and D.D. Gay An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model Mol Pharmacol 22 1982 349 359
4. A.O. Davies, and R.J. Lefkowitz Agonist-promoted high affinity state of the beta-adrenergic receptor in human neutrophils: modulation by corticosteroids J Clin Endocrinol Metab 53 1981 703 708
5. A. DeLean, J.M. Stadel, and R.J. Lefkowitz A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor J Biol Chem 255 1980 7108 7117
6. T. Kenakin Drugs and receptors. An overview of the current state of knowledge Drugs 40 1990 666 687
7. P. Samama, S. Cotecchia, T. Costa, and R.J. Lefkowitz A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model J Biol Chem 268 1993 4625 4636
8. J.M. Weiss, P.H. Morgan, M.W. Lutz, and T.P. Kenakin The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy J Theor Biol 181 1996 381 397
9. K.A. Berg, S. Maayani, J. Goldfarb, C. Scaramellini, P. Leff, and W.P. Clarke Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus Mol Pharmacol 54 1988 94 104
10. S. Sagan, G. Chassaing, L. Pradier, and S. Lavielle Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors J Pharmacol Exp Ther 276 1996 1039 1048
11. T.A. Kohout, S.L. Nicholas, S.J. Perry, G. Reinhart, S. Junger, and R.S. Struthers Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7 J Biol Chem 279 2004 23214 23222
12. S. Maudsley, L. Davidson, A.J. Pawson, R. Chan, R. López de Maturana, and R.P. Millar Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor Cancer Res 64 2004 7533 7544
13. C.J. Caunt, A.R. Finch, K.R. Sedgley, L. Oakley, L.M. Luttrell, and C.A. McArdle Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization J Biol Chem 281 2006 2701 2710
14. J. Bockaert, A. Dumuis, L. Fagni, and P. Marin GPCR-GIP networks: a first step in the discovery of new therapeutic drugs? Curr Opin Drug Discov Dev 7 2004 649 657
15. T. Kenakin, and L.J. Miller Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol Rev 62 2010 265 304
16. B. Martin, W. Chadwick, and T. Yi VENNTURE - a novel Venn diagram investigational tool for multiple pharmacological dataset analysis PLoS One 7 2012 e36911
17. D. Gesty-Palmer, and L.M. Luttrell Refining efficacy: exploiting functional selectivity for drug discovery Adv Pharmacol 62 2011 79 107
18. S. Maudsley, S.A. Patel, S.S. Park, L.M. Luttrell, and B. Martin Functional signaling biases in G protein-coupled receptors: game theory and receptor dynamics Mini Rev Med Chem 12 2012 831 840
19. W.W. Wu, G. Wang, and P.A. Insel Discovery- and target-based protein quantification using iTRAQ and pulsed Q collision induced dissociation (PQD) J Proteomics 75 2012 2480 2487
20. S. Maudsley, W. Chadwick, L. Wang, Y. Zhou, B. Martin, and S.S. Park Bioinformatic approaches to metabolic pathways analysis Methods Mol Biol 756 2011 99 130
21. S. Rajagopal, K. Rajagopal, and R.J. Lefkowitz Teaching old receptors new tricks: biasing seven-transmembrane receptors Nat Rev Drug Discov 9 2012 373 386
22. L. Wang, B. Martin, R. Brenneman, L.M. Luttrell, and S. Maudsley Allosteric modulators of G protein-coupled receptors: future therapeutics for complex physiological disorders J Pharmacol Exp Ther 331 2009 340 348
23. S. Maudsley, J.P. Gent, J.B. Findlay, and D. Donnelly The relationship between the agonist-induced activation and desensitization of the human tachykinin NK2 receptor expressed in Xenopus oocytes Br J Pharmacol 124 1998 675 684
24. D. Donnelly, S. Maudsley, J.P. Gent, R.N. Moser, C.R. Hurrell, and J.B. Findlay Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications Biochem J 339 1999 55 61
25. R. Franco, S. Ferré, and L. Agnati Evidence for adenosine/dopamine receptor interactions: indications for heteromerization Neuropsychopharmacology 23 2000 50 59
26. D. Gesty-Palmer, L. Yuan, and B. Martin β-Arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo Mol Endocrinol 27 2013 296 314
27. A.S. Shaw, and E.L. Filbert Scaffold proteins and immune-cell signaling Nat Rev Immunol 9 2009 47 56
28. W. Wong, and J.D. Scott AKAP signaling complexes: focal points in space and time Nat Rev Mol Cell Biol 5 2004 959 970
29. J. Bockaert, J. Perroy, C. Bécamel, P. Marin, and L. Fagni GPCR interacting proteins (GIPs) in the nervous system: roles in physiology and pathologies Annu Rev Pharmacol Toxicol 50 2012 89 109
30. L.M. Luttrell, S.S. Ferguson, and Y. Daaka Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes Science 283 1999 655 661
31. R.A. Hall, R.T. Premont, and R.J. Lefkowitz Heptahelical receptor signaling: beyond the G protein paradigm J Cell Biol 145 1999 927 932
32. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-arrestins Science 308 2005 512 517
33. K. Rajagopal, R.J. Lefkowitz, and H.A. Rockman When 7 transmembrane receptors are not G protein coupled receptors J Clin Invest 115 2005 2971 2974
34. S. Maudsley G protein-coupled receptor biased agonism: development towards future selective therapeutics Mini Rev Med Chem 12 2012 830
35. U. Wilden, S.W. Hall, and H. Kühn Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments Proc Natl Acad Sci USA 83 1986 1174 1178
36. R.T. Kendall, and L.M. Luttrell Diversity in arrestin function Cell Mol Life Sci 66 2009 2953 2973
37. B.H. Shilton, J.H. McDowell, W.C. Smith, and P.A. Hargrave The solution structure and activation of visual arrestin studied by small angle X-ray scattering Eur J Biochem 269 2002 3801 3809
38. J.D. Violin, S.M. Dewire, W.G. Barnes, and R.J. Lefkowitz G protein-coupled receptor kinase and beta arrestin-mediated desensitization of the angiotensin II type 1A receptor elucidated by diacylglycerol dynamics J Biol Chem 281 2006 36411 36419
39. P.H. McDonald, C.W. Chow, and W.E. Miller Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 Science 290 2000 1574 1577
40. S.K. Shenoy, P.H. McDonald, T.A. Kohout, and R.J. Lefkowitz Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin Science 294 2001 1307 1313
41. R.T. Kendall, E.G. Strungs, and S.M. Rachidi The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1, Ile4, Ile8] angiotensin II regulates a robust G protein-independent signaling network J Biol Chem 286 2011 19880 19891
42. J.M. Beaulieu, R.R. Gainetdinov, and M.G. Caron Akt/GSK3 signaling in the action of psychotropic drugs Annu Rev Pharmacol Toxicol 49 2009 327 347
43. J.M. Beaulieu Morphine-induced mu-opioid receptor internalization: a paradox solved in neurons J Neurosci 25 2005 10061 10063
44. L.M. Luttrell, F.L. Roudabush, and E.W. Choy Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds Proc Natl Acad Sci USA 98 2001 2449 2454
45. A. Tohgo, K.L. Pierce, E.W. Choy, R.J. Lefkowitz, and L.M. Luttrell β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation J Biol Chem 277 2002 9429 9436
46. T.J. Povsic, T.A. Kohout, and R.J. Lefkowitz β-Arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis J Biol Chem 278 2003 51334 51339
47. T. Noma, A. Lemaire, and S.V. Naga Prasad β-Arrestin-mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection J Clin Invest 117 2007 2445 2458
48. J. Kim, S. Ahn, K. Rajagopal, and R.J. Lefkowitz Independent β-arrestin2 and Gq/protein kinase C ζ pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor J Biol Chem 284 2009 11953 11962
49. T. Imamura, J. Huang, and S. Dalle β-Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport J Biol Chem 276 2001 43663 43667
50. J. Barlic, J.D. Andrews, and A.A. Kelvin Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCRI Nat Immunol 1 2000 227 233
51. D.L. Hunton, W.G. Barnes, and J. Kim β-Arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis Mol Pharmacol 67 2005 1229 1236
52. L. Ge, Y. Ly, M. Hollenberg, and K. DeFea A β-arrestin dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis J Biol Chem 278 2003 34418 34426
53. K.A. DeFea, Z.D. Vaughn, E.M. O'Bryan, D. Nishijima, O. Déry, and N.W. Bunnett The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex Proc Natl Acad Sci USA 97 2000 11086 11091
54. C.M. Revankar, C.M. Vines, D.F. Cimino, and E.R. Prossnitz Arrestins block G protein-coupled receptor-mediated apoptosis J Biol Chem 279 2004 24578 24584
55. S. Ahn, J. Kim, M.R. Hara, X.R. Ren, and R.J. Lefkowitz β-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation J Biol Chem 284 2009 8855 8865
56. H. Gao, Y. Sun, and Y. Wu Identification of β-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways Mol Cell 14 2004 303 317
57. J. Kang, Y. Shi, and B. Xiang A nuclear function of β-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription Cell 123 2005 833 847
58. V. Bryja, D. Gradl, A. Schambony, E. Arenas, and G. Schulte β-Arrestin is a necessary component of Wnt/β-catenin signaling in vitro and in vivo Proc Natl Acad Sci USA 104 2007 6690 6695
59. S.M. DeWire, J. Kim, E.J. Whalen, S. Ahn, M. Chen, and R.J. Lefkowitz β-Arrestin-mediated signaling regulates protein synthesis J Biol Chem 283 2008 10611 10620
60. B. Martin, R. Brenneman, K.G. Becker, M. Gucek, R.N. Cole, and S. Maudsley iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease PLoS One 3 2008 e2750
61. W. Chadwick, R. Brenneman, B. Martin, and S. Maudsley Complex and multidimensional lipid raft alterations in a murine model of Alzheimer's disease Int J Alzheimers Dis 2010 2010 604792
62. B. Martin, R. Brenneman, and E. Golden Growth factor signals in neural cells: coherent patterns of interaction control multiple levels of molecular and phenotypic responses J Biol Chem 284 2009 2493 2511
63. T. Hunter Signaling-2000 and beyond Cell 100 2000 113 127
64. J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 103 2000 211 225
65. D. Diviani, L. Baisamy, and A. Appert-Collin AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways Eur J Cell Biol 85 2006 603 610
66. N. Tapon, K. Nagata, N. Lamarche, and A. Hall A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signaling pathways EMBO J 17 1998 1395 1404
67. M. Dickens, J.S. Rogers, and J. Cavanagh A cytoplasmic inhibitor of the JNK signal transduction pathway Science 277 1997 693 696
68. S. Shinoda, S.L. Skradski, and T. Araki Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death Eur J Neurosci 17 2003 2065 2076
69. E.A. Willoughby, and M.K. Collins Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2 J Biol Chem 280 2005 25651 25658
70. S. Maudsley, L. Davidson, and A.J. Pawson Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5 Neuroendocrinology 84 2006 285 300
71. S. Maudsley, Z. Naor, and D. Bonfil Proline-rich tyrosine kinase 2 mediates gonadotropin-releasing hormone signaling to a specific extracellularly regulated kinase-sensitive transcriptional locus in the luteinizing hormone beta-subunit gene Mol Endocrinol 21 2007 1216 1233
72. S. Maudsley, B. Martin, and L.M. Luttrell G protein-coupled receptor signaling complexity in neuronal tissue: implications for novel therapeutics Curr Alzheimer Res 4 2007 3 19
73. X. Song, S. Coffa, H. Fu, and V.V. Gurevich How does arrestin assemble MAPKs into a signaling complex? J Biol Chem 284 2009 685 695
74. Y. Daaka, L.M. Luttrell, and S. Ahn Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase J Biol Chem 273 1998 685 688
75. X. Li, R. MacLeod, and A.J. Dunlop A scanning peptide array approach uncovers association sites within the JNK/β-arrestin signalling complex FEBS Lett 583 2009 3310 3316
76. W.E. Miller, P.H. McDonald, S.F. Cai, M.E. Field, R.J. Davis, and R.J. Lefkowitz Identification of a motif in the carboxyl terminus of β-arrestin2 responsible for activation of JNK3 J Biol Chem 276 2001 27770 27777
77. M.J. Lynch, G.S. Baillie, and A. Mohamed RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with β-arrestin to control the protein kinase A/AKAP79-mediated switching of the β2-adrenergic receptor to activation of ERK in HEK293B2 cells J Biol Chem 280 2005 33178 33189
78. S.K. Shenoy, P.H. McDonald, T.A. Kohout, and R.J. Lefkowitz Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin Science 294 2001 1307 1313
79. S. Mangmool, A.K. Shukla, and H.A. Rockman β-Arrestin-dependent activation of Ca2 +/calmodulin kinase II after β-adrenergic receptor stimulation J Cell Biol 189 2010 573 587
80. P. Wang, and K.A. DeFea Protease-activated receptor-2 simultaneously directs β-arrestin-1-dependent inhibition and Gαq-dependent activation of phosphatidylinositol 3-kinase Biochemistry 45 2006 9374 9385
81. J.D. Scott, and T. Pawson Cell signaling in space and time: where proteins come together and when they're apart Science 326 2009 1220 1224
82. L.M. Luttrell Location, location, location: activation and targeting of MAP kinases by G protein-coupled receptors J Mol Endocrinol 30 2003 117 126
83. D. Gesty-Palmer, P. Flannery, and L. Yuan A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation Sci Transl Med 1 2009 1ra1
84. L.M. Luttrell, and D. Gesty-Palmer Beyond desensitization: physiological relevance of arrestin-dependent signaling Pharmacol Rev 62 2010 305 330
85. E.E. Schadt, J. Lamb, and X. Yang An integrative genomics approach to infer causal associations between gene expression and disease Nat Genet 37 2005 710 717
86. Y. Chen, J. Zhu, and P.Y. Lum Variations in DNA elucidate molecular networks that cause disease Nature 45 2008 429 435
87. S. Maudsley, K.L. Pierce, and A.M. Zamah The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor J Biol Chem 275 2000 9572 9580
88. B. Martin, M. Pearson, and R. Brenneman Conserved and differential effects of dietary energy intake on the hippocampal transcriptomes of females and males PLoS One 3 2008 e2398
89. B. Martin, M. Pearson, and R. Brenneman Gonadal transcriptome alterations in response to dietary energy intake: sensing the reproductive environment PLoS One 4 2009 e4146
90. S.G. Hilsenbeck, W.E. Friedrichs, and R. Schiff Statistical analysis of array expression data as applied to the problem of tamoxifen resistance J Natl Cancer Inst 91 1999 453 459
91. C.M. Schwartz, T. Tavakoli, and C. Jamias Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells J Neurosci Res 90 2012 1367 1381
92. A.M. Stranahan, B. Martin, and S. Maudsley Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer's disease Curr Alzheimer Res 9 2012 86 92
93. J. Quackenbush Microarray data normalization and transformation Nat Genet 32 2002 496 501
94. Y. Zhao, M.C. Li, and R. Simon An adaptive method for cDNA microarray normalization BMC Bioinformatics 6 2005 28
95. T.B. Kepler, L. Crosby, and K.T. Morgan Normalization and analysis of DNA microarray data by self-consistency and local regression Genome Biol 3 2002 RESEARCH0037
96. R. Sasik, E. Calvo, and J. Corbeil Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model Bioinformatics 18 2002 1633 1640
97. M.L. Lee, G.A. Whitmore, H. Björkbacka, and M.W. Freeman Nonparametric methods for microarray data based on exchangeability and borrowed power J Biopharm Stat 15 2005 783 797
98. O.G. Troyanskaya, M.E. Garber, P.O. Brown, D. Botstein, and R.B. Altman Nonparametric methods for identifying differentially expressed genes in microarray data Bioinformatics 18 2002 1454 1461
99. H. Li, C.L. Wood, T.V. Getchell, M.L. Getchell, and A.J. Stromberg Analysis of oligonucleotide array experiments with repeated measures using mixed models BMC Bioinformatics 5 2004 209
100. T.H. Meuwissen, and M.E. Goddard Bootstrapping of gene-expression data improves and controls the false discovery rate of differentially expressed genes Genet Sel Evol 36 2004 191 205
101. A. Reiner, D. Yekutieli, and Y. Benjamini Identifying differentially expressed genes using false discovery rate controlling procedures Bioinformatics 19 2003 368 375
102. W. Chadwick, B. Martin, and M.C. Chapter GIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in rats PLoS One 7 2012 e36975
103. K. Abdelmohsen, S. Srikantan, and K. Tominaga Growth inhibition by miR-519 via multiple p21-inducing pathways Mol Cell Biol 32 2012 2530 2548
104. S.S. Park, W.W. Wu, Y. Zhou, R.F. Shen, B. Martin, and S. Maudsley Effective correction of experimental errors in quantitative proteomics using stable isotope labeling by amino acids in cell culture (SILAC) J Proteomics 75 2012 3720 3732
105. W.W. Wu, R.F. Shen, S.S. Park, B. Martin, and S. Maudsley Precursor ion exclusion for enhanced identification of plasma biomarkers Proteomics Clin Appl 6 2012 304 308
106. J.E. Elias, and S.P. Gygi Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat Methods 4 2007 207 214
107. J.K. Eng, A.L. McCormack, and J.R. Yates An approach to correlate tandem mass spectral data of peptides with amino-acid sequences in a protein database J Am Soc Mass Spectrom 5 1994 976 989
108. D.N. Perkins, D.J.C. Pappin, D.M. Creasy, and J.S. Cottrell Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 20 1999 3551 3567
109. K.R. Clauser, P. Baker, and A.L. Burlingame Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching Anal Chem 71 1999 2871 2882
110. N. Zhang, R. Aebersold, and B. Schwilkowski ProbID: a probabilistic algorithm to identify peptides through sequence database searching using tandem mass spectral data Proteomics 2 2002 1406 1412
111. T.J. Griffin, H. Xie, and S. Bandhakavi iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer J Proteome Res 6 2007 4200 4209
112. L. Dayon, C. Pasquarello, C. Hoogland, J.C. Sanchez, and A. Scherl Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags J Proteomics 73 2012 769 777
113. V. Lange, P. Picotti, B. Domon, and R. Aebersold Selected reaction monitoring for quantitative proteomics Mol Syst Biol 4 2008 222
114. Y.J. Kim, Z. Zaidi-Ainouch, S. Gallien, and B. Domon Mass spectrometry-based detection and quantification of plasma glycoproteins using selective reaction monitoring Nat Protoc 7 2012 859 871
115. E.S. Witze, W.M. Old, K.A. Resing, and N.G. Ahn Mapping protein post-translational modifications with mass spectrometry Nat Methods 4 2007 798 806
116. C.T. Walsh, S. Garneau-Tsodikova, and G.J. Gatto Jr. Protein posttranslational modifications: the chemistry of proteome diversifications Angew Chem Int Ed Engl 44 2005 7342 7372
117. K.S. Kamath, M.S. Vasavada, and S. Srivastava Proteomic databases and tools to decipher post-translational modifications J Proteomics 75 2011 127 144
118. B. Macek, M. Mann, and J.V. Olsen Global and site-specific quantitative phosphoproteomics: principles and applications Annu Rev Pharmacol Toxicol 49 2009 199 221
119. 2-enriched phosphopeptides Anal Biochem 409 2011 81 88
120. T. Hunter The phosphorylation of proteins on tyrosine: its role in cell growth and disease Philos Trans R Soc Lond B 353 1998 583 605
121. M.W. Pinkse, P.M. Uitto, M.J. Hilhorst, B. Ooms, and A.J. Heck Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-nanoLC-ESI-MS/MS and titanium oxide precolumns Anal Chem 76 2004 3935 3943
122. S.S. Jensen, and M.R. Larsen Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques Rapid Commun Mass Spectrom 21 2007 3635 3645
123. J.V. Olsen, M. Vermeulen, and A. Santamaria Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis Sci Signal 3 2010 ra3
124. J.V. Olsen, B. Blagoev, and F. Gnad Global, in vivo, and site-specific phosphorylation dynamics in signaling networks Cell 127 2006 635 648
125. L. Davidson, A.J. Pawson, and R. López de Maturana Gonadotropin-releasing hormone-induced activation of diacylglycerol kinase-zeta and its association with active c-src J Biol Chem 279 2004 11906 11916
126. A.J. Heck Native mass spectrometry: a bridge between interactomics and structural biology Nat Methods 5 2008 927 933
127. Y. Zhong, S.J. Hyung, and B.T. Ruotolo Ion mobility-mass spectrometry for structural proteomics Expert Rev Proteomics 9 2012 47 58
128. Y. Zhou, T. Yi, and S.S. Park Rapid and enhanced proteolytic digestion using electric field-oriented enzyme reactor J Proteomics 74 2011 1030 1035
129. J. Zhong, R. Chaerkady, K. Kandasamy, M. Gucek, R.N. Cole, and A. Pandey The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC J Proteomics 74 2011 294 303
130. I. Martinez-Ferrando, R. Chaerkady, and J. Zhong Identification of targets of c-Src tyrosine kinase by chemical complementation and phosphoproteomics Mol Cell Proteomics 11 2012 355 369
131. S. Gong, G. Yoon, and I. Jang PSIbase: a database of protein sructural interactome map (PSIMAP) Bioinformatics 21 2005 2541 2543
132. K. Venkatesan, J.F. Rual, and A. Vazquez An empirical framework for binary interactome mapping Nat Methods 6 2009 83 90
133. S. Lievens, F. Peelman, K. De Bosscher, I. Lemmens, and J. Tavernier MAPPIT: a protein interaction toolbox built on insights in cytokine receptor signaling Cytokine Growth Factor Rev 22 2011 321 329
134. C.Y. Yang, C.H. Chang, and Y.L. Yu PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database Bioinformatics 24 2008 14 20
135. T.R. Hvidsten, J. Komorowski, A.K. Sandvik, and A. Laegreid Predicting gene function from gene expressions and ontologies Pac Symp Biocomput 6 2010 299 310
136. M.D. Adams, S.E. Celniker, and R.A. Holt The genome sequence of Drosophila melanogaster Science 287 2000 2185 2195
137. M. Liu, A. Liberzon, and S.W. Kong Network-based analysis of affected biological processes in type 2 diabetes models PLoS Genet 3 2007 e96
138. L. Hirschman, A. Yeh, C. Blaschke, and A. Valencia Overview of BioCreAtIvE: critical assessment of information extraction for biology BMC Bioinformatics 6 2005 S1
139. H.K. Dressman, G.G. Muramoto, and N.J. Chao Gene expression signatures that predict radiation exposure in mice and humans PLoS Med 4 2007 e106
140. W. Chadwick, J.P. Boyle, and Y. Zhou Multiple oxygen tension environments reveal diverse patterns of transcriptional regulation in primary astrocytes PLoS One 6 2011 e21638
141. W. Chadwick, Y. Zhou, and S.S. Park Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses PLoS One 5 2010 e14352
142. S.-Y. Kim, and D.J. Volsky PAGE: parametric analysis of geneset enrichment BMC Bioinformatics 6 2005 144 156
143. V.K. Mootha, C.M. Lindgren, and K.F. Eriksson PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat Genet 34 2003 267 273
144. L. Xu, N. Furlotte, and Y. Lin Functional cohesion of gene sets determined by latent semantic indexing of PubMed abstracts PLoS One 6 2011 e18851
145. W. Chadwick, A. Keselman, and S.S. Park Repetitive peroxide exposure reveals pleiotropic mitogen-activated protein kinase signaling mechanisms J Signal Transduct 2011 2011 636951
146. E. Lima-Fernandes, H. Enslen, and E. Camand Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins EMBO J 30 2011 2557 2568
147. I.V. Klewe, S.M. Nielsen, and L. Tarpø Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling Neuropharmacology 54 2008 1215 1222
148. K. Xiao, J. Sun, and J. Kim Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR) Proc Natl Acad Sci USA 107 2010 15299 15304
149. K. Xiao, D.B. McClatchy, and A.K. Shukla Functional specialization of beta-arrestin interactions revealed by proteomic analysis Proc Natl Acad Sci USA 104 2007 12011 12016
150. R.H. Rose, S.J. Briddon, and N.D. Holliday Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks Br J Pharmacol 159 2010 738 750
151. B. Zimmerman, A. Beautrait, and B. Aguila Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs Sci Signal 5 2012 ra33
152. A.C. Emery, J.O. DiRaddo, and E. Miller Ligand bias at metabotropic glutamate 1a receptor: molecular determinants that distinguish β-arrestin from G protein-mediated signaling Mol Pharmacol 82 2012 291 301
153. C. Cottingham, Y. Chen, K. Jiao, and Q. Wang The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo J Biol Chem 286 2011 36063 36075
154. J.A. Allen, J.M. Yost, and V. Setola Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy Proc Natl Acad Sci USA 108 2011 18488 18493
155. S. Blättermann, L. Peters, and P.A. Ottersbach A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer Nat Chem Biol 8 2012 631 638
156. D.J. Watts, and S.H. Strogatz Collective dynamics of 'small-world' networks Nature 393 1998 440 442
157. E.E. Schadt, B. Zhang, and J. Zhu Advances in systems biology are enhancing our understanding of disease and moving us closer to novel disease treatments Genetica 136 2009 259 269
158. E.E. Schadt Molecular networks as sensors and drivers of common human diseases Nature 461 2009 218 223